G+FLAS Life sciences has been developing CRISPR/Cas foundation technologies as well as innovative applications for better human health, including gene therapy drugs, biopharmaceuticals, and novel seeds with desired traits.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 낙성대로 38, 낙성대r&d센터 1층,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.gflas.com
- Keywords
- CRISPR, Gene-Therapy, Cell-Therapy, Biopharmaceuticals, DNA-free genome editing, Vitamin D3 tomatoes.
- HQ
- 서울, 관악구
G+flas Life Sciences, Inc. Questions
G+Flas Life Sciences, Inc.'s website is https://www.gflas.com
G+Flas Life Sciences, Inc.'s LinkedIn profile is https://kr.linkedin.com/company/gflaslife
G+Flas Life Sciences, Inc. has
9 employees.
View email and phone details for 9
employees at G+Flas Life Sciences, Inc..
G+Flas Life Sciences, Inc.'s industry is
Biotechnology Research
G+Flas Life Sciences, Inc.'s top competitors are
Haimbio,
Recerise Therapeutics,
Amtixbio,
Metimedi Co., Ltd.,
The Wall Street Journal,
Spark Biopharma, Inc.,
Cmg Pharmaceutical,
Silal,
E Green Global,
Gi Cell (지아이셀).
G+Flas Life Sciences, Inc.'s categories are Biotechnology Research
G+Flas Life Sciences, Inc.'s founding year is 2014
